Abbott offers two devices for percutaneous, transcatheter ASD closure.
The Amplatzer™ Septal Occluder, CE Marked since 1998, is intended for patients with an ASD in the secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
The Amplatzer Septal Occluder has a wide connecting waist that centers the device and fills the ASD. This occluder—offering the widest range of ASD sizes—can treat defects from 3 mm to 40 mm.
The Amplatzer™ Multi-Fenestrated Septal Occluder - "Cribriform" - is safe and effective for the closure of multifenestrated (cribriform) ASDs.1
Multiple, or fenestrated, ASDs that require closure are not uncommon. In fact, nearly 10% of patients with secundum-type ASD are found to have multifenestrated ASDs.1
In many ways similar to the Amplatzer Septal Occluder, the Amplatzer Cribriform Occluder consists of 2 uniformly sized discs with a very small connecting waist. The waist allows the device to cover a much larger fenestrated area of the atrial septum. This occluder’s disc diameters range from 18 mm to 35 mm.
The Amplatzer Cribriform Occluder is effective in treating a multiple-fenestrated atrial septum.
Both types of Amplatzer Septal Occluders offer these unique features:
- Discs that are designed to securely appose the septal wall on each side of the defect
- Polyester material that promotes occlusion and tissue in-growth
- Ability to be recaptured and redeployed to ensure precise device placement
MAT-2008368 v1.0 | Item approved for Global OUS use only.
- Cho MJ, Song J, Kim SJ, et al. Transcatheter closure of multiple atrial septal defects with the Amplatzer device. Korean Circ J. 2011;41:549-551.